Alberto Quaglia, Eve A. Roberts & Michael Torbenson. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
122
294
.
Samuel Shribman, Maggie Burrows, Rhian Convery, Martina Bocchetta, Carole H. Sudre, Julio Acosta‐Cabronero, David L. Thomas, Godfrey T. Gillett, Emmanuel A. Tsochatzis, Oliver Bandmann, Jonathan D. Rohrer & Thomas T. Warner. (2022) Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease. Movement Disorders 37:8, pages 1728-1738.
Crossref
Bedia Samanci, Erdi Sahin, Basar Bilgic, Zeynep Tufekcioglu, Hakan Gurvit, Murat Emre, Kadir Demir & Hasmet A. Hanagasi. (2021) Neurological features and outcomes of Wilson’s disease: a single-center experience. Neurological Sciences 42:9, pages 3829-3834.
Crossref
Nikita van de Burgt, Silvana van Koningsbruggen, Leonie Behrens, Nicole Leibold, Pilar Martinez-Martinez, Marcel Mannens & Therese van Amelsvoort. (2021) Screening for inborn errors of metabolism in psychotic patients using Next Generation Sequencing. Journal of Psychiatric Research 138, pages 125-129.
Crossref
Ana Martínez, Rubicelia Vargas, Sara E. Pérez-Figueroa & Estrella Ramos. (2021) Copper and neurodegenerative disorders: potential drugs for possible successful treatment. Theoretical Chemistry Accounts 140:6.
Crossref
Jaromír Hanuška, Petr Dušek, Jan Rusz, Olga Ulmanová, Andrea Burgetová & Evžen Růžička. (2020) Eye movement abnormalities are associated with brainstem atrophy in Wilson disease. Neurological Sciences 41:5, pages 1097-1103.
Crossref
Paula C. Zimbrean. 2019. Wilson Disease. Wilson Disease
159
170
.
Wieland Hermann. 2019. Clinical and Translational Perspectives on WILSON DISEASE. Clinical and Translational Perspectives on WILSON DISEASE
271
278
.
Paula C. Zimbrean. 2019. Clinical and Translational Perspectives on WILSON DISEASE. Clinical and Translational Perspectives on WILSON DISEASE
215
225
.
Nanda Kerkar & Eve A. Roberts. 2019. Clinical and Translational Perspectives on WILSON DISEASE. Clinical and Translational Perspectives on WILSON DISEASE
179
193
.
Yannis J. Trakadis, Vanessa Fulginiti & Mark Walterfang. (2017) Inborn errors of metabolism associated with psychosis: literature review and case–control study using exome data from 5090 adult individuals. Journal of Inherited Metabolic Disease 41:4, pages 613-621.
Crossref
Alberto Quaglia, Eve A. Roberts & Michael Torbenson. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver
111
274
.
Eve A. Roberts & Georgios Loudianos. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
926
940.e4
.
Sahil Munjal & Paula C. Zimbrean. 2018. Management of Wilson Disease. Management of Wilson Disease
121
142
.
Eve A. Roberts & Piotr Socha. 2017. Wilson Disease. Wilson Disease
141
156
.
Paula Zimbrean & Joanna Seniów. 2017. Wilson Disease. Wilson Disease
121
140
.
Norberto Anízio Ferreira Frota, Egberto Reis Barbosa, Claudia Sellitto Porto, Leandro Tavares Lucato, Carla Rachel Ono, Carlos Alberto Buchpiguel, Alexandre Aluizio Costa Machado & Paulo Caramelli. (2016) Which factors are associated with global cognitive impairment in Wilson's disease?. Dementia & Neuropsychologia 10:4, pages 320-326.
Crossref
Woori MoonYong Min Ahn. (2016) Wilson Disease Misdiagnosed as Bipolar Disorder. Journal of Korean Neuropsychiatric Association 55:1, pages 67.
Crossref
Vladimir S. Kostić, Marina Svetel, Aleksandra Tomić & Nikola Kresojević. 2015. Neuropsychiatric Symptoms of Movement Disorders. Neuropsychiatric Symptoms of Movement Disorders
261
275
.
Jonghan Kim & Marianne Wessling-Resnick. (2014) Iron and mechanisms of emotional behavior. The Journal of Nutritional Biochemistry 25:11, pages 1101-1107.
Crossref
Yongsheng Han, Fangfang Zhang, Yanghua Tian, Panpan Hu, Bo Li & Kai Wang. (2014) Selective Impairment of Attentional Networks of Alerting in Wilson's Disease. PLoS ONE 9:6, pages e100454.
Crossref
Wieland Hermann. (2014) Morphological and functional imaging in neurological and non-neurological Wilson's patients. Annals of the New York Academy of Sciences 1315:1, pages 24-29.
Crossref
Mark Walterfang & Bart P. van de Warrenburg. (2014) Cognitive impairment in “Other” movement disorders: Hidden defects and valuable clues. Movement Disorders 29:5, pages 694-703.
Crossref
Paula C. Zimbrean & Michael L. Schilsky. (2014) Psychiatric aspects of Wilson disease: a review. General Hospital Psychiatry 36:1, pages 53-62.
Crossref
É. Wenisch, A. De Tassigny, J.-M. Trocello, J. Beretti, N. Girardot-Tinant & F. Woimant. (2013) Cognitive profile in Wilson's disease: A case series of 31 patients. Revue Neurologique 169:12, pages 944-949.
Crossref
N. A. F. Frota, E. R. Barbosa, C. S. Porto, L. T. Lucato, C. R. Ono, C. A. Buchpiguel & P. Caramelli. (2013) Cognitive impairment and magnetic resonance imaging correlations in Wilson's disease. Acta Neurologica Scandinavica 127:6, pages 391-398.
Crossref
A. J. Larner. 2013. Neuropsychological Neurology. Neuropsychological Neurology
110
144
.
Matcheri S. Keshavan & Yoshio Kaneko. (2013) Secondary psychoses: an update. World Psychiatry 12:1, pages 4-15.
Crossref
Mauro Giovanni Carta, Orazio Sorbello, Maria Francesca Moro, Krishna M Bhat, Enrico Demelia, Alessandra Serra, Gioia Mura, Federica Sancassiani, Mario Piga & Luigi Demelia. (2012) Bipolar disorders and Wilson’s disease. BMC Psychiatry 12:1.
Crossref
Eve A. Roberts & Diane W. Cox. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
1110
1126
.
Yitzchak Frank & Stephen Ashwal. 2012. Swaiman's Pediatric Neurology. Swaiman's Pediatric Neurology
1821
1866
.
Richard J. Thompson, Bernard C. Portmann & Eve A. Roberts. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
157
259
.
Pádraig Wright & Marina Zvartau-Hind. 2012. Core Psychiatry. Core Psychiatry
391
420
.
Orazio Sorbello, Daniela Riccio, Margherita Sini, Mauro Carta & Luigi Demelia. (2011) Resolved Psychosis after Liver Transplantation in a Patient with Wilson’s Disease. Clinical Practice & Epidemiology in Mental Health 7:1, pages 182-184.
Crossref
Ronald F. Pfeiffer. 2011. Hyperkinetic Movement Disorders. Hyperkinetic Movement Disorders
681
709
.
Edward C. Lauterbach & Leslie Lester-Burns. 2011. Secondary Schizophrenia. Secondary Schizophrenia
337
347
.
ManojKumar Sahoo, Ajit Avasthi, Madhusmita Sahoo, Manish Modi & Parthasarathy Biswas. (2010) Psychiatric manifestations of wilson′s disease and treatment with electroconvulsive therapy. Indian Journal of Psychiatry 52:1, pages 66.
Crossref
A. J. Larner. 2009. Neuropsychological Neurology. Neuropsychological Neurology
125
156
.
David Myland Kaufman. 2008. Neurología clínica para psiquiatras. Neurología clínica para psiquiatras
407
452
.
. 2007. Clinical Neurology for Psychiatrists. Clinical Neurology for Psychiatrists
401
464
.
. 2007. Clinical Neurology for Psychiatrists. Clinical Neurology for Psychiatrists
401
464
.
Eve A. Roberts & Diane W. Cox. 2006. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
1221
1238
.
George Brewer. 2005. Neurogenetics. Neurogenetics
377
395
.
M. Flint Beal, Anthony E. Lang & Albert C. LudolphPeter A. LeWitt & George J. Brewer. 2010. Neurodegenerative Diseases. Neurodegenerative Diseases
890
908
.
W. Hermann, P. Günther, A. Wagner & T. Villmann. (2005) Klassifikation des Morbus Wilson auf der Basis neurophysiologischer ParameterClassification of Wilson’s disease based on neurophysiological parameters. Der Nervenarzt 76:6, pages 733-739.
Crossref
Alexander Collie. (2005) Cognition in liver disease. Liver International 25:1, pages 1-8.
Crossref
Xianlong Gao, Ziyun Du & Tarun B. Patel. (2005) Copper and Zinc Inhibit Gαs Function. Journal of Biological Chemistry 280:4, pages 2579-2586.
Crossref
R. SquittiD. LupoiP. PasqualettiG. Dal FornoF. VernieriP. ChiovendaL. RossiM. CortesiE. CassettaP. M. Rossini. (2002) Elevation of serum copper levels in Alzheimer’s disease. Neurology 59:8, pages 1153-1161.
Crossref
Joanna Seni?w, Thomas Bak, Jolanta Gajda, Renata Poniatowska & Anna Czlonkowska. (2002) Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease. Movement Disorders 17:5, pages 1077-1083.
Crossref
Katrina Gwinn‐Hardy. (2002) Genetics of parkinsonism. Movement Disorders 17:4, pages 645-656.
Crossref
W. Bono, O. Moutie, A. Benomar, S. Aïdi, M. El Alaoui-Faris, M. Yahyaoui & T. Chkili. (2002) La maladie de Wilson. Étude clinique, thérapeutique et évolutive de 21 cas. La Revue de Médecine Interne 23:5, pages 419-431.
Crossref
Edward C Lauterbach. (2002) Wilson's Disease. Psychiatric Annals 32:2, pages 114-120.
Crossref
Daniel Strausak, Julian F.B Mercer, Hermann H Dieter, Wolfgang Stremmel & Gerd Multhaup. (2001) Copper in disorders with neurological symptoms: Alzheimer’s, Menkes, and Wilson diseases. Brain Research Bulletin 55:2, pages 175-185.
Crossref
Andrés Herrán, María Teresa García-Unzueta, María Dolores Fernández-González, José Luis Vázquez-Barquero, Concepción Alvarez & Jose Antonio Amado. (2000) Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics. Psychiatry Research 94:1, pages 51-58.
Crossref
Y. Estrov, F. Scaglia & O. A. F. Bodamer. (2000) Psychiatric symptoms of inherited metabolic disease. Journal of Inherited Metabolic Disease 23:1, pages 2-6.
Crossref
Katrina A. Gwinn-Hardy. 2000. Parkinson’s Disease and Movement Disorders. Parkinson’s Disease and Movement Disorders
397
410
.
Małgorzata Schlegel-Zawadzka, Andrzej Zięba, Dominika Dudek, Mirosław Krośniak, Maria Szymaczek & Gabriel Nowak. (1999) Serum trace elements in animal models and human depression. Part II. Copper. Human Psychopharmacology: Clinical and Experimental 14:7, pages 447-451.
Crossref
Eve A. Roberts & Diane W. Cox. (1998) 3 Wilson disease. Baillière's Clinical Gastroenterology 12:2, pages 237-256.
Crossref